Sun Pharmaceutical Industries Ltd.

NSE: SUNPHARMA · Healthcare

₹1,838.00

as of 28 Sep 2026

AI verdict · 28 Sep 2026

Bullish 55% confidence

12-month outperformance and price holding above EMA-200 support suggest longer-term uptrend intact, but recent momentum loss and missing…

Strongest bull point

Stock has delivered +14.3% returns over 12 months with +23 percentage-point outperformance versus NIFTY's decline, and price remains above EMA-200 support (₹1,816.7), preserving the longer-term uptrend structure.

Strongest bear point

Recent 1-month decline of -2.5% on volume 66% below average, combined with complete absence of fundamental data and news coverage, suggests institutional conviction is eroding and business deterioration may be unfolding.

Technical Forecast · next 10 trading days

Expected

₹1,866.58 +1.6%

Range

₹1,854.32 – ₹1,870.65

Technical Forecast Fundamental Debate

Free: 5 Forecasts and 5 Debates a month. Log in with your mobile number.

Every call on SUNPHARMA, misses included

Bullish 28 Sep 2026 → now Scores 28 Oct 2026

₹1,838.00 → ₹1,838.00 0.0%

Our accuracy

Every verdict and forecast here is dated and scored when it matures — right or wrong. The first scored results publish a month after launch.

How we score →

More Healthcare